The DCZ publishes its Green Paper 2022: Sustainability in Biotechnology.

Where does the German biotechnology scene currently stand in terms of implementing sustainable corporate strategies? And what motivates biotech companies to develop and implement such strategies?

These are the questions that concern us at DCZ, which is why last year, we reached out to executives of small and medium-sized German biotech companies through a survey.

We gained fascinating insights: The companies are increasingly aware of their ecological and social responsibilities and have recognized that sustainable business practices can be a genuine competitive advantage.

Would you like to learn more about the results of our study?

Go to “DCZ Green Paper 2022” (Englisch)

We will definitely stay on top of this topic and keep you informed about developments in the market!